Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by ANALIAS00on Oct 11, 2017 11:37pm
163 Views
Post# 26802709

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Above 8$ again

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Above 8$ again
Lets pretend that bashing and pumping on this board could make a significant difference on a stock price.    At this point, at a few weeks from approval and 3 months or so from first sales numbers or hints on how sales are going, if things goes as well as we all (almost all) believe, bashing today would have cause 0+0 impact on TH stock.   BUT, pumping and being to positive today would cause a big and bad impact on the stock if sales or other factors cause issues.

My point is, since the majority on this board do see an evident success for TH stock, we should not care or even pay attention to bashers (if any).  We dont need to be rude on anyone that do not share our views, or on others that are just trying to see what we do not want to see or even on those that are really trying to bring the SP down.  At this point we can simply tell them to wait a couple of months to see who were right or wrong.   

I think all questions were asked/answered and whatever the answers, at this point everyone will stay on their positions.  Some will sell at approval, many others will wait ...

Personnaly, closer we get from approval, more painfull it is to wait for it.    And just thinking that after that I will have to wait another several weeks for first hints on sales make me feel sick.    Its been exciting the last 2 years, now the moment of truth is comming shortly ...
Bullboard Posts